期刊文献+

伴血吸虫病的结肠癌和息肉中c-erbB-2表达及AgNOR的意义 被引量:1

Expression of c erbB 2 oncogene and AgNOR in colon cancer and polyp with schistosomiasis
原文传递
导出
摘要 目的研究并存血吸虫病的结肠癌和肠息肉中cerbB2的表达,AgNOR颗粒的数量及特点,探讨血吸虫病与结肠癌发生的关系.方法应用免疫组织化学LSAB法对33例并存血吸虫病的结肠癌和肠息肉(结肠癌21例,伴有肠系膜淋巴结转移17例;肠息肉12例)和20例无血吸虫病的结肠癌和肠息肉(结肠癌10例,伴有肠系膜淋巴结转移4例;肠息肉10例,进行cerbB2标记,并作AgNOR染色.结果肿瘤细胞中癌基因cerbB2的表达呈明显异质性.21例并存血吸虫病的结肠癌中7例阳性(333%),其中5例伴有肠系膜淋巴结转移者均为强阳性;10例无血吸虫病的肠癌中3例阳性(300%),其中2例伴有肠系膜淋巴结转移者均为强阳性;12例并存血吸虫病的肠息肉中5例阳性(417%);10例无血吸虫病的肠息肉中仅1例阳性(100%).并存血吸虫病的肠息肉中cerbB2的表达明显高于无血吸虫病的肠息肉(P<005)AgNOR/核均数示21例并存血吸虫病的肠癌为586±177;10例无血吸虫病的肠癌为475±113;12例并存血吸虫病的肠息内为352±122,其中5例cerbB2阳性的肠息肉为394±? AIM To study the expression of c erbB 2 and AgNOR in colon cancer and polyp with schistosomiasis, and the relationship between schistosomiasis and colon cancer. METHODS From 1992 to 1995, 33 cases of colon cancer and polyp with schistosomiasis and 20 cases of colon cancer and polyp without schistosomiasis were tested for c erbB 2 and AgNOR. RESULTS c erbB 2 positive rate in colon cancer with schistosomiasis was 33 3% (7/21), and in colon cancer without schistosomiasis was 30% (3/10). c erbB 2 positive rate in colon polyp with schistosomiasis was 41 7% (5/12), and in colon polyp without schistosomiasis was 10 0% (1/10). The difference between the two groups was significant ( P <0 05). AgNOR number per nucleus in colon polyp with schistosomiasis was 3 52±1 22, and in colon polyp without schistosomiasis was 2 47±0 89, the difference being significant ( P <0 05). CONCLUSION Colon polyps accompanied by schistosomiasis infection are charaterized by precancerous lesions. Malignant latency in c erbB 2 positive colon cancer was high.
出处 《新消化病学杂志》 1997年第8期504-505,共2页
关键词 血吸虫病 结肠肿瘤 结肠息肉 AGNOR Schistosomiasis mansoni/complications\ \ Colonic neoplasms/metabolism\ \ Colonic polyps/metabolism\ \ Proto_oncogene protein C_erbB_2/analysis
  • 相关文献

同被引文献22

  • 1李静喆,张辉,张仲良,张永清,李其棠.NK-4抑制结肠癌细胞增殖的机制初探[J].中国普通外科杂志,2005,14(10):744-747. 被引量:1
  • 2McKay JA,Loane JF,Ross VG,et al.c-erbB-2 is not a major factor in the development of colorectal cancer[J].Br J Cancer,2002,86(4):568-573.
  • 3D'Emilia J,Bulovas K,D'Ercole K,et al.Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon[J].Oncogene,1989,4(10):1233-1239.
  • 4Had ija MP,Kapitanovic S,Radosevic S,et al.Loss of heterozygosity of DPC4 tumor suppressor gene in human sporadic colon cancer[J].J Mol Med,2001,79(2):128-132.
  • 5MacGrogan D,Pegram M,Slamon D,et al.Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas[J].Oncogene,1997,15(9):1111-1114.
  • 6Ohtaki N,Yamaguchi A,Goi T,et al.Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis[J].Int J Oncol,2001,18(2):265-270.
  • 7Zhang R,Takahashi S,Orita S,et al.p53 gene mutations in rectal cancer associated with schistosomiasis japonica in Chinese patients[J].Cancer Lett,1998,131(2):215-221.
  • 8Ooi A,Takehana T,Li X,et al.Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers:an immunohistochemical and fluorescent in situ hybridization study[J].Mod Pathol,2004,17(8):895-904.
  • 9Soliman AS,Bondy ML,EI-Badawy SA,et al.Contrasting molecular pathology of colorectal carcinoma in Egyptian and western patients[J].Br J Cancer,2001,85(7):1037-1046.
  • 10Osako T,Miyahara M,Uchino S,et al.Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival[J].Oncology,1998,55(6):548-555.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部